# FDA Inspection 1253012 - Vitalant - October 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/vitalant/96725762-d6c0-4fe6-a6d0-e67bdf12e093
Source feed: FDA_Inspections

> FDA Inspection 1253012 for Vitalant on October 29, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1253012
- Company Name: Vitalant
- Inspection Date: 2024-10-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1253012 - 2024-10-29](https://www.keypedia.com/records/fda_inspections/vitalant/e0ad8d9e-74bf-4a3d-ae8e-3f655dcba655)
- [FDA Inspection 1093580 - 2019-06-05](https://www.keypedia.com/records/fda_inspections/vitalant/e95c11a5-d6ab-413d-83a4-618af7cba737)
- [FDA Inspection 1020016 - 2017-06-13](https://www.keypedia.com/records/fda_inspections/vitalant/36638ed9-3be4-468f-87d2-04d0e81c7248)
- [FDA Inspection 948427 - 2015-10-07](https://www.keypedia.com/records/fda_inspections/vitalant/61c1e81a-d6bb-4a05-bbc9-8215ce42f6b2)
- [FDA Inspection 852354 - 2013-10-23](https://www.keypedia.com/records/fda_inspections/vitalant/575ed13b-a9ec-49e5-8eb9-ab20f7eca4a2)

Company: https://www.keypedia.com/companies/vitalant/667ff321-2923-4087-b13b-ad8940ef361f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d